Market revenue in 2023 | USD 6.0 million |
Market revenue in 2030 | USD 10.5 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 68.33% in 2023. Horizon Databook has segmented the Spain biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
With a large population of over 47 billion, Spain is one of the most important markets in Europe for medical products. Small and medium-sized companies dominate 90% of the market and they are responsible for more than 40% of sales. Whereas large-sized companies account for 8% to 10% of sales and generate approximately 60% of sales for the country.
The demand for outsourced services such as regulatory affairs is expected to grow, as there is an increase in medical device imports from countries such as the U.S. and Germany. The medical device contract manufacturing industry in the country is anticipated to grow, as companies are looking for cost-effective and quality manufacturing in the region. All these factors are expected to boost the market in Spain and promote competition among the market players.
Some key players operating in the country are Laboratory Corporation of America Holdings; Eurofins Scientific; Pace Analytical Services, Inc.; and Intertek Group plc. For instance, in July 2022, Labcorp collaborated with a Spanish cancer research center for oncology clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Spain biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account